# AbbVie

> AbbVie develops therapies in immunology, oncology, neuroscience, and eye care, building on the legacy of Humira with next-generation biologics. Its research collaborations with universities advance antibody-drug conjugates and targeted protein degradation.

*Source: [https://selltoscientists.com/companies/abbvie/](https://selltoscientists.com/companies/abbvie/)*

**Industry:** Biopharma
**R&D spend:** $8.0B
**Academic collaborations:** 340
**Patents:** 22,000